Skip to main content
. 2020 Dec;9(6):2920–2937. doi: 10.21037/tau.2020.02.10

Table 1. Ideal selection criteria for trimodal therapy.

Ideal TMT patient* Non-ideal TMT patient (high-risk features)*
cT2 cT3-cT4a disease
Complete TURBT Inability to perform complete TURBT
No hydronephrosis Presence of hydronephrosis
No CIS Presence of extensive CIS
Unifocal tumor Diffuse and multifocal disease
Good bladder function and capacity

*, to be considered an ideal TMT, all characteristics need to be present and no high-risk features. TMT, trimodal therapy; TURBT, transurethral resection of bladder tumor; CIS, carcinoma-in-situ.